The odd-skipped related 1 (OSR1) gene encodes a zinc-finger transcription factor.
OSR1, 8 whereas runt related transcription factor 2 and IKAROS family zinc finger 1 can repress it. 9 OSR1 is also essential for embryonic heart and urogenital formation, and the development of the tongue and kidneys. [10] [11] [12] [13] [14] However, the biological relationship between OSR1 and cancer biology has not yet been well-characterized, except in gastric cancer and renal cell carcinoma. 15 , 16 Otani et al 15 demonstrated that OSR1 mediated tumor suppressive effects through the activation of p53 pathway and the repression of the Wnt/b-catenin signaling pathway in gastric cancer. The Wnt signaling pathway is essential in both normal embryonic development and a variety of cancers. [17] [18] [19] This signaling pathway is exquisitely regulated by a large and complex array of proteins, among which b-catenin is the key protein ( Figure 1 ). 20 When the Wnt signal is weak, bcatenin is incorporated in a destruction complex that contains glycogen synthase kinase 3 (GSK3), adenomatous polyposis coli (APC), axin 1 and casein kinase 1, which results in the phosphorylation of b-catenin and its degradation by a ubiquitin-mediated proteasomal pathway. 21 However, in human cancers, the dissociation of b-catenin from this destruction complex results in the accumulation of b-catenin in the cytoplasm and nucleus, which activates the target genes of the Wnt pathway, such as cyclin D1, matrix metallopeptidase 7
(MMP7) and c-Myc. 22, 23 The detailed mechanism of OSR1-mediated regulation of the Wnt signaling pathway is unclear. The expression and function of OSR1 in human lung cancer and its underlying molecular mechanisms also need to be explored.
In this study, we examined the expression of OSR1 in lung cancer tissues and corresponding normal lung tissues, and analyzed its correlations with clinicopathological factors. We also investigated the underlying mechanisms of OSR1-mediated regulation of the Wnt signaling pathway, and its effects on the proliferative and invasive abilities of lung cancer cells. Organization classification system as squamous cell carcinoma (n = 119) and adenocarcinoma (n = 131). 24 The cancers were classified as well-differentiated (40 cases), moderately differentiated (143 cases) and poorly differentiated (67 cases). According to the seventh edition of the International Union against Cancer TNM Staging System for Lung Cancer, 25 patients were categorized as stage I (n = 41), II (n = 147), III (n = 51) or IV (n = 11). Lymph node metastases were found in 126 cases. We also collected 30 pairs of fresh specimens, including both tumor tissues and corresponding normal tissues, which were stored at À80°C immediately after resection.
| MATERIALS AND METHODS

| Patient data and tissue samples
The study was conducted under the regulations of the Institutional Review Board of China Medical University.
| Immunohistochemistry
All resected specimens were fixed in 10% neutral formalin, embedded in paraffin, and sectioned serially into 4-lm slices. Immunostaining was performed using a streptavidin-peroxidase method. All sections were deparaffinized in xylene, rehydrated in a graded alcohol series, and boiled in 0.01 mol/L citrate buffer for 2.5 minutes in an autoclave. Endogenous peroxidase activity was blocked using hydrogen peroxide, followed by incubation with normal goat serum to reduce non-specific binding. The sections were incubated with anti-OSR1 rabbit polyclonal antibody (1:100; Abcam, Cambridge, MA, USA) at 4°C overnight. Then, the sections were incubated with biotinylated goat anti-rabbit serum IgG secondary antibody and HRP-conjugated streptavidin-biotin (MaiXin, Fuzhou, China). Visualization was performed using DAB chromogen (MaiXin, Fuzhou, China).
Two investigators blinded to the clinical data scored the slides. follows: (i) 1%-25%, (ii) 26%-50%, (iii) 51%-75% and (iv) 76%-100%. Table 1 .
| Western blot
Total protein was extracted from cells in cell lysis buffer (Pierce, Rockford, IL, USA) and quantified using the Bradford method. 27 Nuclear/cytoplasmic proteins were separated using NE-PER Nuclear 
| Cell proliferation assay
Twenty-four hours after transfection, cells were plated in 96-well plates (3000 cells/well) in medium containing 10% FBS. Cell proliferation was detected using Cell Counting Kit-8 (CCK-8, Dojindo
Molecular Technologies, Tokyo, Japan). CCK-8 reagent was added to each well at 1:10 (v/v) per 100 lL and incubated for 2 hours at 37°C. The results were quantitated spectrophotometrically using a test wavelength of 450 nm.
| Colony formation assay
Cells were plated in 6-cm cell culture dishes (800 cells/dish) 24 hours after transfection, then incubated for 14 days. We changed the medium every 4-5 days. Cells were fixed with 4% paraformaldehyde for 20 minutes and stained with hematoxylin for 10 minutes. We counted the colonies with more than 50 cells.
| Matrigel invasion assay
We used Matrigel (BD Biosciences, San Jose, CA, USA) and Transwell chambers with a pore size of 8 lm (Costar, Cambridge, MA, USA), according to the manufacturers' instructions, to assess the invasive ability of transfected cells. Briefly, 100 lL Matrigel (1:7 dilution) was added to each insert. Then, we placed the chambers
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in a 37°C incubator for at least 2 hours; after gelation of the 
| Statistical analysis
All statistical analyses were performed using SPSS 17.0 software (Chicago, IL, USA) and GraphPad Prism 6.0 software (La Jolla, CA, USA (Figure 2A,B) , and 31 cases (24.6%) exhibited low expression. In lung cancer tissues, 111 cases (44.4%) had low expression of OSR1 ( Figure 2C ,E), whereas 139 cases (55.6%) had high expression ( Figure 2D,F) . The expression rate of OSR1 was lower in lung cancers than in normal lung tissues (P < .001) ( Table 2 ). As listed in Table 2 Western blot analysis confirmed that the expression levels of OSR1 were significantly higher in the normal lung tissues than in lung cancer tissues (1.95 AE 0.24 vs 1.07 AE 0.16; n = 30; P < .01) ( Figure 3A,B) . We examined the expression of OSR1 in 6 lung cancer cell lines and a normal bronchial epithelial cell line (HBE). We found that the expression of OSR1 was lower in 4 of 6 lung cancer cell lines, especially in LK2, H661 and H1299, than in HBE cells (Figure 3C,D) . The expression levels of OSR1 and b-catenin were also examined in 20 pairs of lung cancer tissues and corresponding normal lung tissues. We found that OSR1 expression was negatively correlated with that of b-catenin in lung cancer tissues (n = 20; correlation coefficient = À0.675; P < .01) ( Figure 3E ,F).
| OSR1 inhibited the proliferative and invasive abilities of lung cancer cells
To were not markedly changed (P > .05). The expression level of E-cadherin decreased, while N-cadherin and Snail significantly increased in the A549-siOSR1 cells compared to the control cells (P < .05) ( Figure 5F ).
| OSR1 downregulated the expression of bcatenin by inhibiting the transcription of SOX9
A previous study showed that overexpression of OSR1 suppressed the expression of endogenous SOX9 mRNA. 11 The expression of bcatenin increased in the SOX9-overexpressing glioma cells, suggesting a regulatory role for SOX9 in b-catenin signaling. 28 Thus, we hypothesized that OSR1 may inhibit the expression of b-catenin by suppressing SOX9 expression. We altered the expression levels of OSR1 and SOX9 in H1299 or A549 cells, both individually and simultaneously. As shown in Figure 6A cells. As shown in Figure 7 , overexpression of OSR1 inhibited the invasive ability (P < .01) ( Figure 7A ), colony formation (P < .05) (Figure 7C) , and proliferation rate of lung cancer cells (day 5, P < .05) ( Figure 7E ). However, when cotransfected with the OSR1 and bcatenin (CTNNB1) plasmids simultaneously, the inhibitory effects of OSR1 on invasive ability, colony formation and proliferation rate were reversed ( Figure 7A ,C,E) (P < .05). In contrast, the downregulation of OSR1 enhanced the invasive ability (P < .01) ( Figure 7B ), colony formation (P < .01) ( Figure 7D ) and proliferation rate of cancer cells (day 5, P < .01) ( Figure 7F ). These effects were reduced when OSR1 and b-catenin (CTNNB1) were simultaneously knocked down ( Figure 7B ,D,F) (P < .05).
| DISCUSSION
Previous studies on OSR1 were mostly in the field of embryonic development. Reports of OSR1 in tumors were rare. 15, 16 Therefore, As a transcription factor, OSR1 can bind to the promoter of some important genes and regulate their transcriptions. Liu et al 11 found that OSR1 could bind to the promoter of the SOX9 gene, and that the overexpression of OSR1 suppressed the expression of endogenous SOX9 mRNA. SOX9 is a high mobility group box transcription factor, which plays critical roles in embryogenesis and human cancers. [29] [30] [31] [32] In chondrocyte fate determination and maintenance, SOX9 inhibits Wnt signaling by promoting b-catenin phosphorylation and subsequent degradation. 33 However, Liu et al 
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